ESSA Pharma Announces Overnight Marketed Equity Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil prices, producer inflation ease
- Oil pares losses after reports Houthis attacked Saudi Aramco refinery
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
ESSA Pharma (EPIX) Prices Equity Offering at $0.20/Share
December 13, 2017 8:57 AM ESTESSA Pharma Inc. (NASDAQ: EPIX), a pharmaceutical company focused on the development of novel small molecule drugs for the treatment of prostate cancer, is pleased to announce today that the Company has priced its previously announced offering of equity securities (the "Offering"). Pursuant to the Offering, ESSA intends to issue common shares in the capital of the Company (the "Common Shares") at a price of US$0.20 per Common Share (the "Common Share Price").
The Offering will be undertaken on a best efforts basis pursuant to the terms and... More
ESSA Pharma (EPIX) Halted, News Pending
December 13, 2017 8:52 AM ESTESSA Pharma (NASDAQ: EPIX) Halted, News Pending
... More